Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: Association with clinicopathological parameters

Chi Ying Wu, Wei Hwa Lee, Jia Yi Wang, Hung Chiang, Junn Liang Chang, Wen Chiuan Tsai, Lai Fa Sheu, Jong Shiaw Jin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Accumulated evidence reveals that increased cyclooxygenase-2 (COX-2) is involved in the development of colorectal cancer. Our purpose was to quantitate COX-2 expression in colorectal cancers using tissue microarray analysis and look for an association with clinicopathological stage. Immunohistochemical analysis of COX-2 was performed in tissue microarray slides containing 90 specimens including 32 well-differentiated, 35 moderately differentiated, and 23 poorly differentiated colorectal adenocarcinomas. All colorectal adenocarcinomas showed significant immunohistochemical expression of COX-2 when compared to normal colon epithelia. However, there was no significant difference in immunostaining scores between poorly, moderately, and well-differentiated tumors (195 ± 28, 214 ± 26 and 200 ± 24, respectively). The COX-2 immunostaining score correlated significantly with T stage (P <0.05) but not with N or M stage. The positive expression rates of CK20 were 97% for welldifferentiated, 94% for moderately differentiated, and 65% for poorly differentiated colorectal adenocarcinomas, suggesting that CK20 may not be an effective discriminator between poorly differentiated colorectal adenocarcinoma and metastatic adenocarcinoma.

Original languageEnglish
Pages (from-to)298-304
Number of pages7
JournalChinese Journal of Physiology
Volume49
Issue number6
Publication statusPublished - 2006
Externally publishedYes

Fingerprint

Cyclooxygenase 2
Adenocarcinoma
Colorectal Neoplasms
Tissue Array Analysis
Colon
Epithelium
Neoplasms

Keywords

  • Adenocarcinoma
  • Colorectal
  • Cyclooxygenase-2
  • Cytokeratin 20

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma : Association with clinicopathological parameters. / Wu, Chi Ying; Lee, Wei Hwa; Wang, Jia Yi; Chiang, Hung; Chang, Junn Liang; Tsai, Wen Chiuan; Sheu, Lai Fa; Jin, Jong Shiaw.

In: Chinese Journal of Physiology, Vol. 49, No. 6, 2006, p. 298-304.

Research output: Contribution to journalArticle

Wu, Chi Ying ; Lee, Wei Hwa ; Wang, Jia Yi ; Chiang, Hung ; Chang, Junn Liang ; Tsai, Wen Chiuan ; Sheu, Lai Fa ; Jin, Jong Shiaw. / Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma : Association with clinicopathological parameters. In: Chinese Journal of Physiology. 2006 ; Vol. 49, No. 6. pp. 298-304.
@article{9b7fee3370bd4ebdbaf169285afb4f22,
title = "Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: Association with clinicopathological parameters",
abstract = "Accumulated evidence reveals that increased cyclooxygenase-2 (COX-2) is involved in the development of colorectal cancer. Our purpose was to quantitate COX-2 expression in colorectal cancers using tissue microarray analysis and look for an association with clinicopathological stage. Immunohistochemical analysis of COX-2 was performed in tissue microarray slides containing 90 specimens including 32 well-differentiated, 35 moderately differentiated, and 23 poorly differentiated colorectal adenocarcinomas. All colorectal adenocarcinomas showed significant immunohistochemical expression of COX-2 when compared to normal colon epithelia. However, there was no significant difference in immunostaining scores between poorly, moderately, and well-differentiated tumors (195 ± 28, 214 ± 26 and 200 ± 24, respectively). The COX-2 immunostaining score correlated significantly with T stage (P <0.05) but not with N or M stage. The positive expression rates of CK20 were 97{\%} for welldifferentiated, 94{\%} for moderately differentiated, and 65{\%} for poorly differentiated colorectal adenocarcinomas, suggesting that CK20 may not be an effective discriminator between poorly differentiated colorectal adenocarcinoma and metastatic adenocarcinoma.",
keywords = "Adenocarcinoma, Colorectal, Cyclooxygenase-2, Cytokeratin 20",
author = "Wu, {Chi Ying} and Lee, {Wei Hwa} and Wang, {Jia Yi} and Hung Chiang and Chang, {Junn Liang} and Tsai, {Wen Chiuan} and Sheu, {Lai Fa} and Jin, {Jong Shiaw}",
year = "2006",
language = "English",
volume = "49",
pages = "298--304",
journal = "Chinese Journal of Physiology",
issn = "0304-4920",
publisher = "Chinese Physiological Society",
number = "6",

}

TY - JOUR

T1 - Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma

T2 - Association with clinicopathological parameters

AU - Wu, Chi Ying

AU - Lee, Wei Hwa

AU - Wang, Jia Yi

AU - Chiang, Hung

AU - Chang, Junn Liang

AU - Tsai, Wen Chiuan

AU - Sheu, Lai Fa

AU - Jin, Jong Shiaw

PY - 2006

Y1 - 2006

N2 - Accumulated evidence reveals that increased cyclooxygenase-2 (COX-2) is involved in the development of colorectal cancer. Our purpose was to quantitate COX-2 expression in colorectal cancers using tissue microarray analysis and look for an association with clinicopathological stage. Immunohistochemical analysis of COX-2 was performed in tissue microarray slides containing 90 specimens including 32 well-differentiated, 35 moderately differentiated, and 23 poorly differentiated colorectal adenocarcinomas. All colorectal adenocarcinomas showed significant immunohistochemical expression of COX-2 when compared to normal colon epithelia. However, there was no significant difference in immunostaining scores between poorly, moderately, and well-differentiated tumors (195 ± 28, 214 ± 26 and 200 ± 24, respectively). The COX-2 immunostaining score correlated significantly with T stage (P <0.05) but not with N or M stage. The positive expression rates of CK20 were 97% for welldifferentiated, 94% for moderately differentiated, and 65% for poorly differentiated colorectal adenocarcinomas, suggesting that CK20 may not be an effective discriminator between poorly differentiated colorectal adenocarcinoma and metastatic adenocarcinoma.

AB - Accumulated evidence reveals that increased cyclooxygenase-2 (COX-2) is involved in the development of colorectal cancer. Our purpose was to quantitate COX-2 expression in colorectal cancers using tissue microarray analysis and look for an association with clinicopathological stage. Immunohistochemical analysis of COX-2 was performed in tissue microarray slides containing 90 specimens including 32 well-differentiated, 35 moderately differentiated, and 23 poorly differentiated colorectal adenocarcinomas. All colorectal adenocarcinomas showed significant immunohistochemical expression of COX-2 when compared to normal colon epithelia. However, there was no significant difference in immunostaining scores between poorly, moderately, and well-differentiated tumors (195 ± 28, 214 ± 26 and 200 ± 24, respectively). The COX-2 immunostaining score correlated significantly with T stage (P <0.05) but not with N or M stage. The positive expression rates of CK20 were 97% for welldifferentiated, 94% for moderately differentiated, and 65% for poorly differentiated colorectal adenocarcinomas, suggesting that CK20 may not be an effective discriminator between poorly differentiated colorectal adenocarcinoma and metastatic adenocarcinoma.

KW - Adenocarcinoma

KW - Colorectal

KW - Cyclooxygenase-2

KW - Cytokeratin 20

UR - http://www.scopus.com/inward/record.url?scp=34247119305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247119305&partnerID=8YFLogxK

M3 - Article

C2 - 17357536

AN - SCOPUS:34247119305

VL - 49

SP - 298

EP - 304

JO - Chinese Journal of Physiology

JF - Chinese Journal of Physiology

SN - 0304-4920

IS - 6

ER -